Literature DB >> 2677313

The estimation of moments: a technical note.

M K Charter1.   

Abstract

The calculation of several common pharmacokinetic parameters requires estimates of both the area under the curve of the concentration of the drug in a sampled fluid vs. time, and also the first moment about t = 0 of this area. It is proposed that the methods used to estimate these quantities should make consistent assumptions about the concentration of the drug. There appears to be an inconsistency in the standard published formulas in the case where concentration is interpolated linearly. A more consistent formula is derived.

Mesh:

Year:  1989        PMID: 2677313     DOI: 10.1007/bf01059028

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  6 in total

1.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

2.  Estimation of noncompartmental parameters: a technical note.

Authors:  A Dunne; P King
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

3.  Theorem on the apparent volume of distribution and the amount of drug in the body at steady state.

Authors:  D P Vaughan
Journal:  J Pharm Sci       Date:  1984-02       Impact factor: 3.534

4.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

5.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

6.  Theorems on the apparent volume of distribution of a linear system.

Authors:  D P Vaughan
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

  6 in total
  3 in total

1.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

2.  Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Hannah Joerissen; Beate Müller-Tiemann; Heiner Apeler; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

3.  The pharmacodynamics and pharmacokinetics of a novel thromboxane receptor blocking drug vapiprost (GR32191) after single intravenous doses in healthy subjects.

Authors:  M Thomas; R J Keery; M K Charter; N L Scully; J E Chilton; P Lumley
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.